Login / Signup

Next-generation ctDNA-driven clinical trials in precision immuno-oncology.

Charu AggarwalNatasha B Leighl
Published in: Journal for immunotherapy of cancer (2023)
Keyphrases
  • clinical trial
  • palliative care
  • circulating tumor
  • phase ii
  • open label
  • double blind
  • study protocol
  • phase iii
  • cell free
  • circulating tumor cells